just a reminder of what IPIX's (fka CTIX) *volume* avgs

New Post Public Reply Private Reply Replies (0) Message Board
4kids 4kids #47042
404
just a reminder of what IPIX's (fka CTIX) *volume* avgs were .. from 2014 to yesterday .. done @ 6 month intervals (approx)

note: 90 day is far less easy to manipulate than the 10 day (by NR/MMs)
and equally telling what NR *shows* for daily *liquidity*


Detailed Quote:CTIX
CELLCEUTIX CORPORATION
4.80Up 0.26 (5.73 %)AS OF 3:59:49PM ET 12/11/2014


Last Trade 4.80
Trade Time 3:59:49pm ET

Change 0.26
% Change 5.73%


Bid 4.79
Bid Size 2100

Ask 4.81
Ask Size 100


Open 4.525
Day High 4.89 ** 46c *liquidity*
Day Low 4.43
Previous Close
12/10/2014 4.54

52-Week High
12/11/2014 4.89

52-Week Low
04/15/2014 1.49


Price Performance (Last 52 Weeks)
12/10/2014 +177.78%


Volume 1,313,689
Volume (10 day Average) 1,005,153
Volume (90 day Average) 531,026



Detailed Quote:CTIX
CELLCEUTIX CORPORATION
3.43Up 0.37 (12.09 %)AS OF 2:20:54PM ET 07/17/2015


Last Trade 3.43
Trade Time 2:20:54pm ET

Change 0.37
% Change 12.09%


Bid 3.42
Bid Size 1100

Ask 3.43
Ask Size 300


Open 3.07
Day High 3.59 ** 54c *liquidity*
Day Low 3.05
Previous Close
07/16/2015 3.06

52-Week High
12/12/2014 4.93

52-Week Low
08/01/2014 1.60


Price Performance (Last 52 Weeks)
07/16/2015 +80.00%


Volume 651,428
Volume (10 day Average) 227,748
Volume (90 day Average) 219,840


Detailed Quote:CTIX
CELLCEUTIX CORPORATION
1.526Down -0.041 (-2.62 %)AS OF 3:59:54PM ET 12/15/2015


Last Trade 1.526
Trade Time 3:59:54pm ET

Change -0.041
% Change -2.62%


Open 1.57
Day High 1.57 ** 9c *liquidity*
Day Low 1.48
Previous Close
12/14/2015 1.567

52-Week High
01/08/2015 4.74

52-Week Low
10/23/2015 0.9412


Price Performance (Last 52 Weeks)
12/14/2015 -67.35%


Volume 185,550
Volume (10 day Average) 218,360
Volume (90 day Average) 308,038



Detailed Quote:CTIX ** note volume *avgs* .. look familiar? (2 years)
CELLCEUTIX CORPORATION
1.48Up 0.00 (0.00 %)AS OF 3:59:48PM ET 06/17/2016


Last Trade 1.48
Trade Time 3:59:48pm ET

Change 0.00
% Change 0.00%


Bid 1.44
Bid Size 2100

Ask 1.48
Ask Size 200


Open 1.48
Day High 1.49 ** 7c *liquidity*
Day Low 1.42
Previous Close
06/16/2016 1.48

52-Week High
07/20/2015 3.65

52-Week Low
10/23/2015 0.9412


Price Performance (Last 52 Weeks)
06/16/2016 -42.19%


Volume 116,434
Volume (10 day Average) 175,532
Volume (90 day Average) 210,581



Detailed Quote:CTIX
CELLCEUTIX CORPORATION
1.21Up 0.06 (5.22 %)AS OF 3:59:45PM ET 12/15/2016


Last Trade 1.21
Trade Time 3:59:45pm ET

Change 0.06
% Change 5.22%


Bid 1.16
Bid Size 100

Ask 1.23
Ask Size 100


Open 1.18
Day High 1.25 ** 10c *liquidity*
Day Low 1.15
Previous Close
12/14/2016 1.15

52-Week High
03/29/2016 1.92

52-Week Low
12/06/2016 0.91


Price Performance (Last 52 Weeks)
12/13/2016 -22.67%


Volume 188,164
Volume (10 day Average) 166,097
Volume (90 day Average) 145,505


Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.74Down -0.02 (-2.63 %)AS OF 3:59:58PM ET 06/16/2017


Last Trade 0.74
Trade Time 3:59:58pm ET

Change -0.02
% Change -2.63%


Bid 0.71
Bid Size 1000

Ask 0.75
Ask Size 1000


Open 0.76
Day High 0.78 ** 8c *liquidity*
Day Low 0.70
Previous Close
06/15/2017 0.76

52-Week High
06/24/2016 1.55

52-Week Low
05/10/2017 0.63


Price Performance (Last 52 Weeks)
06/15/2017 -50.65%


Volume 291,610
Volume (10 day Average) 318,614
Volume (90 day Average) 267,707



Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.785Up 0.00705 (0.91 %)AS OF 3:59:57PM ET 12/15/2017


Last Trade 0.785
Trade Time 3:59:57pm ET

Change 0.00705
% Change 0.91%


Open 0.76
Day High 0.815 ** .055c *liquidity*
Day Low 0.76
Previous Close
12/14/2017 0.77795

52-Week High
12/16/2016 1.26

52-Week Low
05/10/2017 0.63


Price Performance (Last 52 Weeks) ** note the %
12/14/2017 -32.35%


Volume 153,680
Volume (10 day Average) 563,214
Volume (90 day Average) 202,489



Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.428Up 0.00975 (2.33 %)AS OF 3:25:46PM ET 06/15/2018


Last Trade 0.428
Trade Time 3:25:46pm ET

Change 0.00975
% Change 2.33%


Bid 0.395
Bid Size 6000

Ask 0.43
Ask Size 5500


Open 0.405
Day High 0.43 ** 4c *liquidity*
Day Low 0.39
Previous Close
06/14/2018 0.41825

52-Week High
12/06/2017 1.17

52-Week Low
05/09/2018 0.35


Price Performance (Last 52 Weeks)
06/14/2018 -43.48%


Volume 149,996
Volume (10 day Average) 122,353
Volume (90 day Average) 202,752


and last (but not least) .. IPIX yesterday ..

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.59Up 0.21 (55.26 %)AS OF 4:00:01PM ET 06/29/2018


Last Trade 0.59
Trade Time 4:00:01pm ET

Change 0.21
% Change 55.26%


Bid 0.58
Bid Size 3700

Ask 0.59
Ask Size 2000


Open 0.34
Day High 0.59 ** 25c *liquidity*
Day Low 0.34
Previous Close
06/28/2018 0.38

52-Week High
12/06/2017 1.17

52-Week Low
06/21/2018 0.325


Price Performance (Last 52 Weeks)
06/28/2018 -60.62%


Volume 1,392,203
Volume (10 day Average) 238,605
Volume (90 day Average) 211,120


4kids

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 310

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 410

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 303

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 386

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 347

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading

Top 5 Most Recently Viewed Articles

International Isotopes Enhances Growth with New Facilities

Updated Category News Views 139

International Isotopes Expands Its Operational Footprint International Isotopes, Inc. (OTCQB: INIS) has announced a significant expansion of its operational capabilities with a strategic land acquisition and a new facility lease agreement. This initiative is part of a broader strategy aimed at enhancing the Company's footprint in the radiopharmaceuticals sector. Strategic...

Continue Reading
Humana Achieves Top Honors in Customer Experience Again

Updated Category News Views 80

Humana Excels in Customer Experience for Four Straight Years Humana has once again secured the top position in customer experience among health insurers, according to a recent survey conducted by Forrester. This marks the fourth consecutive year that Humana has achieved this prestigious recognition, reaffirming its commitment to delivering exceptional service and care to...

Continue Reading
BrainStorm Cell Therapeutics Presents Insights into ALS Treatment

Updated Category News Views 128

BrainStorm Cell Therapeutics Webinar on ALS Treatments BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a prominent innovator in adult stem cell therapeutics for neurodegenerative diseases, will be hosting an insightful webinar on current developments in treating amyotrophic lateral sclerosis (ALS). This event is designed to provide essential updates and perspectives...

Continue Reading
Celebrating Excellence: The 2024 Employer Branding Awards Unveiled

Updated Category News Views 235

Overview of the Employer Branding Creativity Awards The "2024 Employer Branding Creativity Awards" organized by the Employer Branding Institute, recognized 75 exemplary companies for their innovative contributions to employer branding. Sponsored by Jaguar Land Rover China, this prestigious event not only celebrates creativity but also demonstrates the rising influence of...

Continue Reading
Battery Recycling Market Expected to Hit $77.1 Billion by 2034

Updated Category News Views 210

Battery Recycling Market Overview The battery recycling market is gaining remarkable traction worldwide, projected to soar to $77.1 billion by 2034. This forecast represents a significant growth trajectory from a valuation of $26.9 billion in 2024, indicating a compound annual growth rate (CAGR) of 11.2% from 2025 to 2034. Impact of Government Regulations Government...

Continue Reading